Bank of Montreal Can Has $18.11 Million Position in Molina Healthcare, Inc. (NYSE:MOH)

Bank of Montreal Can lowered its position in Molina Healthcare, Inc. (NYSE:MOH) by 9.2% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 58,976 shares of the company’s stock after selling 5,956 shares during the period. Bank of Montreal Can owned 0.10% of Molina Healthcare worth $18,105,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in Molina Healthcare by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 6,585,954 shares of the company’s stock valued at $2,379,571,000 after purchasing an additional 23,715 shares during the last quarter. Capital World Investors grew its holdings in Molina Healthcare by 0.3% during the fourth quarter. Capital World Investors now owns 5,490,147 shares of the company’s stock valued at $1,983,645,000 after purchasing an additional 14,775 shares during the last quarter. Wellington Management Group LLP grew its holdings in Molina Healthcare by 12.8% during the fourth quarter. Wellington Management Group LLP now owns 3,831,100 shares of the company’s stock valued at $1,384,215,000 after purchasing an additional 436,060 shares during the last quarter. Capital Research Global Investors grew its holdings in Molina Healthcare by 5.4% during the fourth quarter. Capital Research Global Investors now owns 2,430,283 shares of the company’s stock valued at $878,086,000 after purchasing an additional 123,894 shares during the last quarter. Finally, Capital International Investors grew its holdings in Molina Healthcare by 0.9% during the first quarter. Capital International Investors now owns 1,665,801 shares of the company’s stock valued at $684,361,000 after purchasing an additional 15,264 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Wall Street Analysts Forecast Growth

MOH has been the topic of several analyst reports. Cantor Fitzgerald reiterated an “overweight” rating and set a $406.00 price target on shares of Molina Healthcare in a report on Tuesday, September 10th. Truist Financial lowered their price target on Molina Healthcare from $440.00 to $400.00 and set a “buy” rating on the stock in a report on Monday, July 15th. Stephens reissued an “equal weight” rating and issued a $320.00 price objective on shares of Molina Healthcare in a research report on Thursday, July 25th. JPMorgan Chase & Co. reduced their price objective on Molina Healthcare from $420.00 to $395.00 and set an “overweight” rating for the company in a research report on Wednesday, July 10th. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on Molina Healthcare from $354.00 to $353.00 and set a “hold” rating for the company in a research report on Monday, July 29th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $378.00.

Insider Activity

In other news, Director Steven J. Orlando sold 1,000 shares of the business’s stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total value of $339,210.00. Following the sale, the director now owns 18,025 shares in the company, valued at approximately $6,114,260.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director Steven J. Orlando sold 1,000 shares of the business’s stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total value of $339,210.00. Following the sale, the director now owns 18,025 shares in the company, valued at approximately $6,114,260.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Maurice Hebert sold 393 shares of Molina Healthcare stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $346.52, for a total value of $136,182.36. Following the completion of the transaction, the chief accounting officer now directly owns 9,473 shares of the company’s stock, valued at $3,282,583.96. The disclosure for this sale can be found here. 1.10% of the stock is owned by corporate insiders.

Molina Healthcare Stock Up 1.0 %

MOH opened at $341.86 on Friday. Molina Healthcare, Inc. has a fifty-two week low of $282.96 and a fifty-two week high of $423.92. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.57 and a quick ratio of 1.57. The firm’s fifty day moving average price is $340.66 and its two-hundred day moving average price is $341.76. The company has a market capitalization of $20.03 billion, a P/E ratio of 18.55, a P/E/G ratio of 1.21 and a beta of 0.57.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Wednesday, July 24th. The company reported $5.86 earnings per share for the quarter, topping analysts’ consensus estimates of $5.73 by $0.13. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The firm had revenue of $9.88 billion for the quarter, compared to the consensus estimate of $9.75 billion. During the same quarter in the previous year, the company earned $5.65 earnings per share. The business’s revenue was up 18.7% compared to the same quarter last year. On average, analysts anticipate that Molina Healthcare, Inc. will post 23.5 EPS for the current year.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.